Would be good to understand the seperated revenue streams especially the recurring revenue, not just lumping it all together including clinical trial and one off equipment sales.
Ann: Rimidi Partnership for Respiratory Clinical Management, page-13
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.89M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 67157 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 185998 | 1 |
View Market Depth
| Last trade - 10.00am 30/07/2024 (20 minute delay) ? |
| ADR (ASX) Chart |
Day chart unavailable